Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Status:
Terminated
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gene therapy may improve the body's ability to fight cancer or make the cancer
more sensitive to chemotherapy. Drugs used in chemotherapy use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: This phase I trial is studying the side effects and best dose of gene therapy
together with chemotherapy in treating patients with advanced solid tumors or non-Hodgkin's
lymphoma.